hydrochlorothiazide has been researched along with Diabetic Neuropathies in 2 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| " We aimed to investigate the effect of sodium restriction and the diuretic hydrochlorothiazide, separately and in combination, added to RAAS blockade on residual albuminuria in patients with type 2 diabetic nephropathy." | 5.19 | Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial. ( Binnenmars, SH; Groen, H; Hemmelder, MH; Krikken, JA; Kwakernaak, AJ; Laverman, GD; Navis, G; Visser, FW; Woittiez, AJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weir, MR | 1 |
| Kwakernaak, AJ | 1 |
| Krikken, JA | 1 |
| Binnenmars, SH | 1 |
| Visser, FW | 1 |
| Hemmelder, MH | 1 |
| Woittiez, AJ | 1 |
| Groen, H | 1 |
| Laverman, GD | 1 |
| Navis, G | 1 |
1 trial available for hydrochlorothiazide and Diabetic Neuropathies
| Article | Year |
|---|---|
Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial.
Topics: Aged; Albuminuria; Blood Pressure; Diabetic Neuropathies; Diet, Sodium-Restricted; Diuretics; Double | 2014 |
1 other study available for hydrochlorothiazide and Diabetic Neuropathies
| Article | Year |
|---|---|
Salt, hypertension, and proteinuria in diabetic nephropathy.
Topics: Albuminuria; Diabetic Neuropathies; Diet, Sodium-Restricted; Diuretics; Female; Humans; Hydrochlorot | 2014 |